Evolving and expanding scope of lupus-inducing drugs

Affiliations

Editorial

Robert L Rubin. Ann Rheum Dis. 2019 Apr.

. 2019 Apr;78(4):443-445.

doi: 10.1136/annrheumdis-2018-214785. Epub 2019 Feb 13.

¹ Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, NM 87131, USA rlrubin@salud.unm.edu.

No abstract available

Keywords: autoimmune diseases; autoimmunity; systemic lupus erythematosus.

Conflict of interest statement

Competing interests: None declared.

Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database.
Arnaud L, Mertz P, Gavand PE, Martin T, Chasset F, Tebacher-Alt M, Lambert A, Muller C, Sibilia J, Lebrun-Vignes B, Salem JE. Arnaud L, et al. Ann Rheum Dis. 2019 Apr;78(4):504-508. doi: 10.1136/annrheumdis-2018-214598. Epub 2019 Feb 4. Ann Rheum Dis. 2019. PMID: 30793701